Semler Scientific, Inc. (NASDAQ:SMLR) Shares Bought by Rhumbline Advisers

Rhumbline Advisers lifted its position in shares of Semler Scientific, Inc. (NASDAQ:SMLR) by 27.1% in the 2nd quarter, Holdings Channel reports. The fund owned 6,197 shares of the company’s stock after buying an additional 1,320 shares during the period. Rhumbline Advisers’ holdings in Semler Scientific were worth $213,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in SMLR. LSV Asset Management raised its position in shares of Semler Scientific by 58.0% during the first quarter. LSV Asset Management now owns 252,887 shares of the company’s stock worth $7,387,000 after purchasing an additional 92,851 shares during the period. Acadian Asset Management LLC increased its stake in shares of Semler Scientific by 68.2% in the first quarter. Acadian Asset Management LLC now owns 165,876 shares of the company’s stock worth $4,843,000 after acquiring an additional 67,282 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its stake in shares of Semler Scientific by 20.6% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 98,252 shares of the company’s stock worth $2,870,000 after purchasing an additional 16,777 shares in the last quarter. Janney Montgomery Scott LLC bought a new stake in Semler Scientific in the first quarter worth approximately $700,000. Finally, Greenwood Capital Associates LLC increased its position in Semler Scientific by 38.1% during the first quarter. Greenwood Capital Associates LLC now owns 21,883 shares of the company’s stock worth $639,000 after buying an additional 6,036 shares during the last quarter. Institutional investors own 49.37% of the company’s stock.

Semler Scientific Stock Up 1.1 %

Shares of SMLR stock opened at $23.77 on Friday. The company has a market cap of $167.96 million, a PE ratio of 8.52 and a beta of 0.96. Semler Scientific, Inc. has a 12 month low of $20.88 and a 12 month high of $53.38. The business’s 50 day moving average is $27.47 and its two-hundred day moving average is $28.94.

Semler Scientific (NASDAQ:SMLR) last announced its quarterly earnings data on Monday, August 5th. The company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.56 by $0.08. The business had revenue of $14.47 million during the quarter. Semler Scientific had a net margin of 25.62% and a return on equity of 21.17%.

Insider Transactions at Semler Scientific

In related news, CEO Douglas Murphy-Chutorian sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.35, for a total value of $283,500.00. Following the completion of the transaction, the chief executive officer now owns 60,220 shares in the company, valued at approximately $1,707,237. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 13.00% of the company’s stock.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.